PunchReps ask FG to crack down on fake, adulterated food productsThe Jerusalem PostIran prolongs talks in stalemate to punish Trump ahead of US midterms, officials sayESPNFree agents: Stroud, Miller lead top options to addInquirerPagasa: Northern portions of PH to be most affected by RosalRTP DesportoFC Porto vence PSV na Youth LeagueESPN DeportesKonaté habla de la "mala suerte" de Real Madrid con los árbitrosDaily MaverickBAIL DENIED: ‘Dangerous pattern’: Shadrack Sibiya denied bail over threats and wiped cellphoneInquirer EntertainmentChristiane Amanpour says she’s leaving CNN after 43 yearsZDF heuteEntdecken Sie das ZDF-Nachrichtenstudion-tvRegierung räumt Versäumnisse ein: Frankreich arbeitet Krawalle in Untersuchungsausschuss aufANSA SportEuropa League: il danese Krogh arbitra la Juve, greco Fotias per il MilanGolem.deAnzeige: Nur bis Donnerstag | Amazon verkauft smarten Luftreiniger zum reduzierten Preis
KioskNews
The Daily Newsstand · Free, Always
Tuesday, October 20, 2026
Language
Seeking Alpha·United States·

AstraZeneca and Oracle strike AI collaboration to speed up clinical trials

Translate

Dulan Lokuwithana

Divided Forces: Red and Blue Climbing Rope Knots Pulling in Opposite Directions
  • AstraZeneca (AZN) on Tuesday announced a collaboration with Oracle (ORCL) to accelerate and optimize clinical studies by combining its scientific, R&D, and regulatory expertise with the tech giant’s real-world data, cloud infrastructure, and AI capabilities.
  • The partnership will advance across multiple regions, including the U.S., the Middle East, and Europe, in compliance with applicable regulatory frameworks supporting Astra’s (AZN) core therapeutic areas such as oncology, the companies said.
  • As part of the collaboration, AstraZeneca (AZN) and Oracle Health and Life Sciences will initially target multiple stages of R&D, including clinical trial enrollments, diagnosis, and drug-safety monitoring.
  • The inaugural program will focus on clinical research on hypertension in Abu Dhabi to help investigators identify trial subjects and improve patient recruitment in partnership with UAE-based healthcare company ‌M42.
  • Financial terms of the deal were not disclosed.

Recommended For You

Create Your Free Account to Keep Reading

Get the confidence to navigate an uncertain market with free breaking news and stock alerts.

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.